Observational studyFrontiers in endocrinology2021

Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study.

Junpei Sanada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.